Skip to main content
Clinical Trials/IRCT2016041016473N7
IRCT2016041016473N7
Completed
Phase 2

Effect of N-Acetyl Cysteine on liver and kidney function tests after surgical bypass in obstructive jaundice patients

Tabriz University of Medical Science0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Obstruction of bile duct.
Sponsor
Tabriz University of Medical Science
Enrollment
30
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tabriz University of Medical Science

Eligibility Criteria

Inclusion Criteria

  • Age above 18 years and below 75; unable to treta with ERCP or radiologic intervention; common bile diameter over 10 mm; no indication for resection of obstructive jaundice (choledochal cyst or Whipple procedure); bilirubin level over 5 mg/dl
  • Exclusion criteria: possibility of surgical resection (Whipple procedure or bile duct tumor resection); any contraindication for acetylcysteine injection (e.g. asthma, bronchospasm, angioedema or known hypersensitivity); liver cirrhosis or need for liver transplant according to clinical or surgical findings for any reason; known renal failure or heart failure; need for mechanical ventilation before surgery, septic shock resistant to inotrope ( Systolic blood pressure less than 90\) before surgery; preoperative biliary drainage by ERCP or radiologic intervention; liver enzymes (ALT, AST) greater than 10 times the normal; acute viral hepatitis or any history of drug toxicity; known liver disease such as autoimmune hepatitis; hemolysis cases

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials